CERT
HealthcareCertara, Inc.
$6.62+0.06 (+0.91%)
Prev Close
$6.56
Open
$6.58
High
$6.71
Low
$6.45
Volume
3.37M
Market Cap
$1.13B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Certara, Inc. (CERT) has been dominated by selling, with 1 insider purchase totaling $200.0K and 7 insider sales totaling $1.57M. The most recent insider transaction was by Feehery William F (CHIEF EXECUTIVE OFFICER), who purchased $200.0K worth of shares on Nov 11, 2025. Certara, Inc. operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $1.13B.
Buys (12M)
1
$200.0K
Sells (12M)
7
$1.57M
Net Activity
Net Seller
$1.37M
Active Insiders
7
last 12 mo
CERT Price Chart
CERT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 11, 2025↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Buy | 24,096 | $8.30 | $200.0K | 0 |
| Sep 9, 2025↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 51,224 | $10.92 | $559.4K | 0 |
| May 30, 2025↗ | Anhalt Rona | Chief Human Resources Officer | Sell | 1,965 | $11.40 | $22.4K | 0 |
| May 30, 2025↗ | Corcoran Daniel | SVP and General Counsel | Sell | 6,607 | $11.40 | $75.3K | 0 |
| Apr 1, 2025↗ | Aspbury Robert | PRESIDENT, PREDICTIVE TECH | Sell | 15,846 | $9.90 | $156.9K | 0 |
| Apr 1, 2025↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 53,834 | $9.90 | $533.0K | 0 |
| Apr 1, 2025↗ | Gallagher John E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 14,176 | $9.90 | $140.3K | 0 |
| Apr 1, 2025↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 8,209 | $9.90 | $81.3K | 0 |
| Oct 7, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 5,409 | $11.03 | $59.7K | 0 |
| Oct 4, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 1,742 | $10.99 | $19.1K | 0 |
| Sep 9, 2024↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 51,224 | $11.29 | $578.3K | 0 |
| Jul 1, 2024↗ | Aspbury Robert | PRESIDENT, SCIENTIFIC SOFTWARE | Sell | 862 | $13.85 | $11.9K | 0 |
| Apr 2, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 14,427 | $16.85 | $243.2K | 0 |
| Apr 1, 2024↗ | Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWARE | Sell | 10,625 | $17.88 | $190.0K | 0 |
| Apr 1, 2024↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 42,629 | $17.88 | $762.2K | 0 |
| Apr 1, 2024↗ | Gallagher John E | CHIEF FINANCIAL OFFICER | Sell | 9,077 | $17.88 | $162.3K | 0 |
| Apr 1, 2024↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 5,951 | $17.88 | $106.4K | 0 |
| Apr 1, 2024↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 2,578 | $17.88 | $46.1K | 0 |
| Apr 1, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 6,955 | $17.88 | $124.4K | 0 |
| Apr 1, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 9,244 | $17.92 | $165.6K | 0 |
| Mar 5, 2024↗ | Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWARE | Sell | 7,311 | $18.88 | $138.0K | 0 |
| Mar 5, 2024↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 4,050 | $18.88 | $76.5K | 0 |
| Mar 5, 2024↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 2,373 | $18.88 | $44.8K | 0 |
| Mar 5, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 3,660 | $18.88 | $69.1K | 0 |
| Mar 4, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 3,000 | $18.28 | $54.8K | 0 |
| Feb 20, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 5,000 | $18.00 | $90.0K | 0 |
| Feb 12, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 6,000 | $18.00 | $108.0K | 0 |
| Dec 26, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 6,000 | $18.00 | $108.0K | 0 |
| Sep 11, 2023↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 51,224 | $14.60 | $747.9K | 0 |
| Aug 21, 2023↗ | BROSHY ERAN | Director | Buy | 5,000 | $15.81 | $79.1K | 0 |
| Aug 1, 2023↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 1,057 | $19.47 | $20.6K | 0 |
| Jun 30, 2023↗ | Aspbury Robert | PRESIDENT, SIMCYP | Sell | 862 | $18.19 | $15.7K | 0 |
| Jun 5, 2023↗ | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Sell | 19,104 | $21.55 | $411.7K | 0 |
| May 11, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 5,000 | $20.82 | $104.1K | 0 |
| Apr 14, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 5,000 | $23.66 | $118.3K | 0 |
| Mar 31, 2023↗ | Aspbury Robert | PRESIDENT, SIMCYP | Sell | 6,934 | $23.80 | $165.0K | 0 |
| Mar 31, 2023↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 25,634 | $23.80 | $610.1K | 0 |
| Mar 31, 2023↗ | Pedersen Leif E | PRESIDENT, SOFTWARE | Sell | 4,039 | $23.80 | $96.1K | 0 |
| Mar 31, 2023↗ | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Sell | 8,277 | $23.80 | $197.0K | 0 |
| Mar 31, 2023↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 1,251 | $23.80 | $29.8K | 0 |
| Mar 31, 2023↗ | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Sell | 4,426 | $23.80 | $105.3K | 0 |
| Mar 31, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 3,847 | $23.80 | $91.6K | 0 |
| Mar 31, 2023↗ | Virkler Drayton | PRESIDENT, REG & ACCES | Sell | 1,166 | $23.80 | $27.8K | 0 |
| Mar 6, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 10,000 | $21.45 | $214.5K | 0 |
| Mar 5, 2023↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 17,557 | $18.88 | $331.5K | 0 |
| Feb 2, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 15,000 | $20.00 | $300.0K | 0 |
| Nov 22, 2022↗ | Pedersen Leif E | PRESIDENT, SOFTWARE | Sell | 51,223 | $15.55 | $796.5K | 0 |
| Nov 14, 2022↗ | SLAINE MASON P | Director | Sell | 250,000 | $15.56 | $3.89M | 0 |
| Nov 14, 2022↗ | WALSH MATTHEW M | Director | Sell | 12,059 | $14.74 | $177.8K | 0 |
| Nov 9, 2022↗ | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Sell | 2,387 | $13.48 | $32.2K | 0 |
Showing 1–50 of 136
1 / 3
CERT Insider Buying Activity
The following table shows recent insider purchases of Certara, Inc. (CERT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 11, 2025↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Buy | 24,096 | $8.30 | $200.0K | 0 |
| Aug 21, 2023↗ | BROSHY ERAN | Director | Buy | 5,000 | $15.81 | $79.1K | 0 |
CERT Insider Selling Activity
The following table shows recent insider sales of Certara, Inc. (CERT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 51,224 | $10.92 | $559.4K | 0 |
| May 30, 2025↗ | Anhalt Rona | Chief Human Resources Officer | Sell | 1,965 | $11.40 | $22.4K | 0 |
| May 30, 2025↗ | Corcoran Daniel | SVP and General Counsel | Sell | 6,607 | $11.40 | $75.3K | 0 |
| Apr 1, 2025↗ | Aspbury Robert | PRESIDENT, PREDICTIVE TECH | Sell | 15,846 | $9.90 | $156.9K | 0 |
| Apr 1, 2025↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 53,834 | $9.90 | $533.0K | 0 |
| Apr 1, 2025↗ | Gallagher John E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 14,176 | $9.90 | $140.3K | 0 |
| Apr 1, 2025↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 8,209 | $9.90 | $81.3K | 0 |
| Oct 7, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 5,409 | $11.03 | $59.7K | 0 |
| Oct 4, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 1,742 | $10.99 | $19.1K | 0 |
| Sep 9, 2024↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 51,224 | $11.29 | $578.3K | 0 |
| Jul 1, 2024↗ | Aspbury Robert | PRESIDENT, SCIENTIFIC SOFTWARE | Sell | 862 | $13.85 | $11.9K | 0 |
| Apr 2, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 14,427 | $16.85 | $243.2K | 0 |
| Apr 1, 2024↗ | Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWARE | Sell | 10,625 | $17.88 | $190.0K | 0 |
| Apr 1, 2024↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 42,629 | $17.88 | $762.2K | 0 |
| Apr 1, 2024↗ | Gallagher John E | CHIEF FINANCIAL OFFICER | Sell | 9,077 | $17.88 | $162.3K | 0 |
| Apr 1, 2024↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 5,951 | $17.88 | $106.4K | 0 |
| Apr 1, 2024↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 2,578 | $17.88 | $46.1K | 0 |
| Apr 1, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 6,955 | $17.88 | $124.4K | 0 |
| Apr 1, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 9,244 | $17.92 | $165.6K | 0 |
| Mar 5, 2024↗ | Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWARE | Sell | 7,311 | $18.88 | $138.0K | 0 |
| Mar 5, 2024↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 4,050 | $18.88 | $76.5K | 0 |
| Mar 5, 2024↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 2,373 | $18.88 | $44.8K | 0 |
| Mar 5, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 3,660 | $18.88 | $69.1K | 0 |
| Mar 4, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 3,000 | $18.28 | $54.8K | 0 |
| Feb 20, 2024↗ | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Sell | 5,000 | $18.00 | $90.0K | 0 |
| Feb 12, 2024↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 6,000 | $18.00 | $108.0K | 0 |
| Dec 26, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 6,000 | $18.00 | $108.0K | 0 |
| Sep 11, 2023↗ | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Sell | 51,224 | $14.60 | $747.9K | 0 |
| Aug 1, 2023↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 1,057 | $19.47 | $20.6K | 0 |
| Jun 30, 2023↗ | Aspbury Robert | PRESIDENT, SIMCYP | Sell | 862 | $18.19 | $15.7K | 0 |
| Jun 5, 2023↗ | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Sell | 19,104 | $21.55 | $411.7K | 0 |
| May 11, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 5,000 | $20.82 | $104.1K | 0 |
| Apr 14, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 5,000 | $23.66 | $118.3K | 0 |
| Mar 31, 2023↗ | Aspbury Robert | PRESIDENT, SIMCYP | Sell | 6,934 | $23.80 | $165.0K | 0 |
| Mar 31, 2023↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 25,634 | $23.80 | $610.1K | 0 |
| Mar 31, 2023↗ | Pedersen Leif E | PRESIDENT, SOFTWARE | Sell | 4,039 | $23.80 | $96.1K | 0 |
| Mar 31, 2023↗ | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Sell | 8,277 | $23.80 | $197.0K | 0 |
| Mar 31, 2023↗ | SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | Sell | 1,251 | $23.80 | $29.8K | 0 |
| Mar 31, 2023↗ | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Sell | 4,426 | $23.80 | $105.3K | 0 |
| Mar 31, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 3,847 | $23.80 | $91.6K | 0 |
| Mar 31, 2023↗ | Virkler Drayton | PRESIDENT, REG & ACCES | Sell | 1,166 | $23.80 | $27.8K | 0 |
| Mar 6, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 10,000 | $21.45 | $214.5K | 0 |
| Mar 5, 2023↗ | Feehery William F | CHIEF EXECUTIVE OFFICER | Sell | 17,557 | $18.88 | $331.5K | 0 |
| Feb 2, 2023↗ | Traynor Richard M. | SVP AND GENERAL COUNSEL | Sell | 15,000 | $20.00 | $300.0K | 0 |
| Nov 22, 2022↗ | Pedersen Leif E | PRESIDENT, SOFTWARE | Sell | 51,223 | $15.55 | $796.5K | 0 |
| Nov 14, 2022↗ | SLAINE MASON P | Director | Sell | 250,000 | $15.56 | $3.89M | 0 |
| Nov 14, 2022↗ | WALSH MATTHEW M | Director | Sell | 12,059 | $14.74 | $177.8K | 0 |
| Nov 9, 2022↗ | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Sell | 2,387 | $13.48 | $32.2K | 0 |
CERT Insiders
Similar Stocks to CERT
GEHC
GE HealthCare Technologies Inc.
$70.76+0.60%
$32.05B
VEEV
Veeva Systems Inc.
$178.26-1.40%
$29.72B
TEM
Tempus AI, Inc.
$50.20+1.35%
$8.82B
BTSG
BrightSpring Health Services, Inc. Common Stock
$38.01-1.63%
$8.02B
HQY
HealthEquity, Inc.
$77.29+0.65%
$6.85B
DOCS
Doximity, Inc.
$24.32+0.19%
$4.75B
HNGE
Hinge Health, Inc.
$44.77+0.70%
$3.63B
PRVA
Privia Health Group, Inc.
$21.57-0.74%
$2.87B